查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1544121

全球经皮给药市场

Transdermal Drug Delivery
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球经皮给药市场预计将达到2,353亿美元

2023年全球经皮给药市场预计为806亿美元，预计到2030年将达2,353亿美元，2023年至2030年复合年增长率为16.5%。被动交付是本报告分析的细分市场之一，预计复合年增长率为 15.1%，到分析期结束时将达到 1,235 亿美元。在分析期间，主动交付领域的复合年增长率预计为 18.4%。

美国市场预计221亿美元，中国预计复合年增长率15.7%

预计到 2023 年，美国经皮给药市场将达到 221 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达356亿美元，2023-2030年分析期间复合年增长率为15.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 15.1% 和 14.2%。在欧洲，德国的复合年增长率预计约为 14.6%。

全球经皮给药市场 - 主要趋势与驱动因素总结

什么是经皮给药？

经经皮给药是一种以受控方式透过皮肤给药以达到全身作用的方法。这种药物输送系统对于以非侵入性、方便且有效的方式绕过胃肠道将药物直接输送到血液中至关重要。经皮吸收贴片是经皮给药系统最常见的形式，用于治疗多种疾病，包括慢性疼痛、荷尔蒙失衡和尼古丁成瘾。经皮给药的价值在于其能够提高患者的依从性，降低副作用的风险，并长期维持恆定的治疗药物水平。

经皮如何改善治疗效果？

经皮给药可透过提供药物的受控和持续释放来改善治疗效果。这种输送方法使药物能够以稳定的速率被吸收，从而维持血液中的最佳治疗水平。透过绕过胃肠道，经皮系统避免了胃刺激和首过代谢等问题，药物在到达体循环之前可能会被降解。这增加了生物有效性并减少了所需剂量。此外，经皮吸收贴片使用方便，可自行给药，提高病患对规定治疗方法的遵从性。总的来说，这些好处有助于实现更有效、更可靠的治疗结果。

为什么对经皮给药系统的需求不断增加？

由于几个重要因素，对经皮给药系统的需求不断增加。需要长期药物管理的慢性疾病和病症的流行推动了对方便有效的药物传递方法的需求。药物配方和皮肤渗透技术的进步扩大了可经皮给药的药物范围，增加了它们的适用性。对提高患者依从性和减轻频繁给药方案负担的关注也推动了对经皮系统的需求。此外，经皮给药的非侵入性使其成为希望避免注射或口服药物的患者的一个有吸引力的选择。新经皮技术的发展以及医疗保健行业对这些系统的日益接受正在进一步推动其采用。

经皮给药市场成长的因素有哪些？

经皮给药市场的成长受到多种因素的推动。慢性病和需要长期用药的疾病的盛行率不断增加，对有效、方便的给药系统产生了巨大的需求。药物配方、皮肤渗透促进剂和贴片设计的技术进步将扩大经皮给药系统的功效和范围，并促进其采用。此外，专注于提高患者依从性和对非侵入性药物输送选择的需求也有助于市场成长。经皮系统应用的扩大，例如疼痛管理、荷尔蒙补充疗法和戒烟，也进一步推动了需求。此外，有利的监管政策和新型经皮技术的开拓正在支持市场扩张。医疗保健产业对经皮给药的接受度不断提高，以及为提高其性能和可靠性而不断进行的研究和开发工作，支撑了市场的成长潜力。

受访企业范例（共12家）

  • Antares Pharma, Inc.
  • Bayer AG
  • Durect Corporation
  • Iontera, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • Novartis AG
  • Pantec Biosolutions AG
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP15288

Global Transdermal Drug Delivery Market to Reach US$235.3 Billion by 2030

The global market for Transdermal Drug Delivery estimated at US$80.6 Billion in the year 2023, is expected to reach US$235.3 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Passive Delivery, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$123.5 Billion by the end of the analysis period. Growth in the Active Delivery segment is estimated at 18.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$22.1 Billion While China is Forecast to Grow at 15.7% CAGR

The Transdermal Drug Delivery market in the U.S. is estimated at US$22.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$35.6 Billion by the year 2030 trailing a CAGR of 15.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.1% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global Transdermal Drug Delivery Market - Key Trends & Drivers Summarized

What is Transdermal Drug Delivery and Why is it Crucial?

Transdermal Drug Delivery is a method of administering medications through the skin in a controlled manner to achieve systemic effects. This delivery system is crucial for providing a non-invasive, convenient, and effective way of delivering drugs directly into the bloodstream, bypassing the gastrointestinal tract. Transdermal patches are the most common form of transdermal drug delivery systems, used to treat various conditions such as chronic pain, hormonal imbalances, and nicotine addiction. The significance of transdermal drug delivery lies in its ability to improve patient compliance, reduce the risk of side effects, and maintain consistent therapeutic drug levels over extended periods.

How Does Transdermal Drug Delivery Improve Therapeutic Outcomes?

Transdermal Drug Delivery improves therapeutic outcomes by offering a controlled and sustained release of medication. This delivery method ensures that drugs are absorbed at a steady rate, maintaining optimal therapeutic levels in the bloodstream, which enhances efficacy and reduces the frequency of dosing. By bypassing the gastrointestinal tract, transdermal systems avoid issues such as gastric irritation and first-pass metabolism, which can degrade the drug before it reaches systemic circulation. This leads to better bioavailability and reduced dosage requirements. Additionally, transdermal patches are user-friendly and can be self-administered, improving patient adherence to prescribed treatment regimens. These benefits collectively contribute to more effective and reliable therapeutic outcomes.

Why is the Demand for Transdermal Drug Delivery Systems Increasing?

The demand for Transdermal Drug Delivery systems is increasing due to several key factors. The rising prevalence of chronic diseases and conditions that require long-term medication management drives the need for convenient and effective drug delivery methods. Advances in drug formulation and skin penetration technologies have expanded the range of drugs that can be delivered transdermally, increasing their applicability. The focus on improving patient compliance and reducing the burden of frequent dosing regimens also fuels the demand for transdermal systems. Additionally, the non-invasive nature of transdermal drug delivery makes it an attractive option for patients who prefer to avoid injections or oral medications. The development of novel transdermal technologies and the growing acceptance of these systems in the healthcare industry further support their adoption.

What Factors are Driving the Growth of the Transdermal Drug Delivery Market?

The growth in the Transdermal Drug Delivery market is driven by several factors. The increasing prevalence of chronic diseases and conditions requiring long-term medication creates a significant demand for effective and convenient drug delivery systems. Technological advancements in drug formulation, skin penetration enhancers, and patch design enhance the efficacy and range of transdermal delivery systems, driving their adoption. The focus on improving patient compliance and the need for non-invasive drug delivery options also contribute to market growth. The expanding applications of transdermal systems, including pain management, hormone replacement therapy, and smoking cessation, further boost demand. Additionally, favorable regulatory policies and the development of novel transdermal technologies support market expansion. The growing acceptance of transdermal drug delivery in the healthcare industry, coupled with ongoing research and development efforts to enhance their performance and reliability, underscores the market's potential for growth.

Select Competitors (Total 12 Featured) -

  • Antares Pharma, Inc.
  • Bayer AG
  • Durect Corporation
  • Iontera, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • Novartis AG
  • Pantec Biosolutions AG
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transdermal Drug Delivery - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Preference for Non-Invasive Drug Delivery Methods
    • Advancements in Patch Technology and Formulations
    • Increasing Incidence of Chronic Diseases
    • Rising Demand for Controlled Release and Targeted Delivery
    • Expansion of Applications Beyond Pain Management
    • Market Growth in Geriatric and Pediatric Populations
    • Impact of Biotechnology and Nanotechnology Innovations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Transdermal Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Active by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Smoking Cessation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Smoking Cessation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Smoking Cessation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transdermal Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION